risperidone has been researched along with Coronary Stenosis in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Coronary Stenosis: Narrowing or constriction of a coronary artery.
Excerpt | Relevance | Reference |
---|---|---|
"Pulmonary embolism was seen in our patient a week after starting risperidone." | 1.48 | Pseudo-Wellens' syndrome in pulmonary embolism. ( Basnyat, S; Bhattacharya, PT; Sedhai, YR, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sedhai, YR | 1 |
Basnyat, S | 1 |
Bhattacharya, PT | 1 |
1 other study available for risperidone and Coronary Stenosis
Article | Year |
---|---|
Pseudo-Wellens' syndrome in pulmonary embolism.
Topics: Antipsychotic Agents; Chest Pain; Coronary Stenosis; Electrocardiography; Humans; Male; Pulmonary Em | 2018 |